Home Cart 0 Sign in  
X

[ CAS No. 95201-93-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 95201-93-7
Chemical Structure| 95201-93-7
Chemical Structure| 95201-93-7
Structure of 95201-93-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 95201-93-7 ]

Related Doc. of [ 95201-93-7 ]

Alternatived Products of [ 95201-93-7 ]

Product Details of [ 95201-93-7 ]

CAS No. :95201-93-7 MDL No. :MFCD00052081
Formula : C6H5BrO3S Boiling Point : -
Linear Structure Formula :- InChI Key :UFTXASQYKJFRKI-UHFFFAOYSA-N
M.W : 237.07 Pubchem ID :2777611
Synonyms :

Calculated chemistry of [ 95201-93-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.32
TPSA : 74.77 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.07
Log Po/w (XLOGP3) : 2.68
Log Po/w (WLOGP) : 2.0
Log Po/w (MLOGP) : 1.08
Log Po/w (SILICOS-IT) : 2.6
Consensus Log Po/w : 2.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.2
Solubility : 0.149 mg/ml ; 0.000627 mol/l
Class : Soluble
Log S (Ali) : -3.9
Solubility : 0.0297 mg/ml ; 0.000125 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.03
Solubility : 2.23 mg/ml ; 0.0094 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.52

Safety of [ 95201-93-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 95201-93-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 95201-93-7 ]
  • Downstream synthetic route of [ 95201-93-7 ]

[ 95201-93-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 5118-06-9 ]
  • [ 95201-93-7 ]
YieldReaction ConditionsOperation in experiment
76% With bromine In acetic acid at 20℃; for 24 h; To a solution of 10g of 1 (63.2 mmol) in 22 mL of acetic acid was added 3.24 mL of bromine (63.2 mmol) then the mixture was stirred at room temperature for 24h. The solution was poured on 50 mL of water and extracted with 50 mL of CH2Cl2. The organic phase was washed twice with 50 ml of water then dried over MgSO4 and the solvent was removed at reduced pressure. The crude product was purified by flash chromatography on silica gel (CH2Cl2 - EP : 1/2) to afford 11.3 g of 2 (76 percent). m.p. = 86 °C 1H NMR (CDCl3): 3.92 (s, 3H), 7.38 (s, 1H), 9.74 (s, 1H) 13C NMR (CDCl3): 52.2, 102.6, 103.8, 128.1, 160.4, 165.8. MS (EI) : m/z = 236 (M+.)
10% With N-Bromosuccinimide In tetrahydrofuran; methanol at 0 - 20℃; for 6 h; General procedure: NBS (63 mg,0.35 mmol) was added to a solution of 1 (100 mg, 0.70 mmol) in 10 mL of THF – CH3OH (1:1, v/v) at 0 C and the mixture was stirred at roomtemperature. After 2 h, NBS (50.4 mg, 0.28 mmol) was added again to the mixture at 0 C, and it was stirred at room temperature for 2 h. The solvent wasremoved in vacuo, and water (15 mL) was added to the residue. The aqueouslayer was extracted three times with EtOAc (30 mL). The organic layers weregathered together, washed with water and brine, dried over MgSO4, filtered,and concentrated in vacuo. Et2O (10 mL) was added to the dry residue todiscard succinimide. The filtrate was concentrated in vacuo, and heptane(10 mL) was added to the dry residue to afford 4 as an orange powder (68.6 mg,44percent yield).
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 35, p. 5005 - 5008
[2] Tetrahedron Letters, 2011, vol. 52, # 12, p. 1288 - 1291
[3] Synthesis, 1984, vol. NO. 10, p. 847 - 850
[4] Tetrahedron Letters, 2017, vol. 58, # 26, p. 2537 - 2541
[5] Patent: US4748183, 1988, A,
[6] Patent: EP249236, 1991, B1,
[7] Tetrahedron Letters, 2017, vol. 58, # 26, p. 2537 - 2541
  • 2
  • [ 95201-94-8 ]
  • [ 95201-93-7 ]
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 26, p. 2537 - 2541
Same Skeleton Products
Historical Records